Cargando…
Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer
Ovarian cancer is a serious threat to women's health; its early diagnosis rate is low and prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is a combination of platinum and paclitaxel chemotherapy based on surgery. The recurrence and progression of ovaria...
Autores principales: | Liu, Shuna, Wu, Ming, Wang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176232/ https://www.ncbi.nlm.nih.gov/pubmed/34093804 http://dx.doi.org/10.7150/jca.47695 |
Ejemplares similares
-
Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment
por: Wang, Ting, et al.
Publicado: (2023) -
The oncogenic and prognostic role of PDK1 in the progression and metastasis of ovarian cancer
por: Yao, Shasha, et al.
Publicado: (2021) -
Update on the utility of prognostic biomarkers in ovarian cancer
por: Markman, Maurie
Publicado: (2009) -
UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023) -
Screening and prognostic value of potential biomarkers for ovarian cancer
por: Li, Huiqin, et al.
Publicado: (2021)